Breaking News
2 hours ago
Vaibhavi M.
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
The Lancet consensus renames PCOS to PMOS, backed by 56 organisations after a 14-year process, to better reflect hormonal and metabolic dysfunction affecting 1 in 8 women globally.
Vaibhavi M.
Telangana's life sciences sector hits $145B valuation on Rs. 84,000 crore investment, reshaping India's API and CDMO supply landscape.
Pharma Now Editorial Team

Cipla secures the first AB-rated gVentolin approval in the U.S., clearing the FDA's complex pMDI equivalence threshold while posting record FY26 revenue.
Pharma Now Editorial Team

Alembic Pharma secures USFDA tentative approval for Darolutamide Tablets 300 mg, targeting a $3.155B U.S. oncology generic market.
Pharma Now Editorial Team
